Evolent Health Inc (EVH)
32.79
+0.06
(+0.18%)
USD |
NYSE |
Mar 28, 16:00
32.80
+0.01
(+0.03%)
After-Hours: 20:00
Evolent Health Cash from Financing (TTM): 281.34M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 281.34M |
September 30, 2023 | 354.84M |
June 30, 2023 | 565.29M |
March 31, 2023 | 562.65M |
December 31, 2022 | 131.54M |
September 30, 2022 | 203.29M |
June 30, 2022 | 30.85M |
March 31, 2022 | -25.34M |
December 31, 2021 | -29.55M |
September 30, 2021 | -114.36M |
June 30, 2021 | -128.86M |
March 31, 2021 | -100.02M |
December 31, 2020 | -11.86M |
September 30, 2020 | 0.808M |
June 30, 2020 | 111.44M |
March 31, 2020 | 106.69M |
December 31, 2019 | -35.54M |
September 30, 2019 | 257.66M |
June 30, 2019 | 156.62M |
Date | Value |
---|---|
March 31, 2019 | 185.97M |
December 31, 2018 | 274.02M |
September 30, 2018 | 13.70M |
June 30, 2018 | 181.50M |
March 31, 2018 | 152.58M |
December 31, 2017 | 165.56M |
September 30, 2017 | 293.23M |
June 30, 2017 | 130.78M |
March 31, 2017 | 141.53M |
December 31, 2016 | 150.18M |
September 30, 2016 | 5.863M |
June 30, 2016 | 4.834M |
March 31, 2016 | 214.19M |
December 31, 2015 | 214.16M |
September 30, 2015 | 209.18M |
June 30, 2015 | 209.12M |
March 31, 2015 | -0.961M |
December 31, 2014 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-128.86M
Minimum
Jun 2021
565.29M
Maximum
Jun 2023
125.17M
Average
109.06M
Median
Cash from Financing (TTM) Benchmarks
American Shared Hospital Services | -1.157M |
Novo Integrated Sciences Inc | 5.094M |
Astrana Health Inc | 3.421M |
Cryo-Cell International Inc | -2.073M |
P3 Health Partners Inc | 116.17M |